Letters to the Editor

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax

Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Division of Hematology and Oncology, Cook Children’s Medical Center, Fort Worth, TX
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO
Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO
Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; Department of Oncology; Hematological Malignancies Program, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pediatrics, Division of Children’s Cancer and Blood Disorders, University of Colorado Anschutz Medical Campus, Aurora, CO
Haematologica Early view Oct 22, 2026 https://doi.org/10.3324/haematol.2026.300808